STAT

Opinion: Women should be in biotech and health care boardrooms. But mandating they be there is not the answer

True change in the life sciences sector will come only when it adopts a comprehensive approach to diversity for everyone — not with a signature on a bill requiring companies…

A bill that made its way through the California House and Senate is now sitting on Gov. Jerry Brown’s desk, waiting to be signed. If that happens, public companies headquartered in California would be required to have at least one woman on their boards of directors by the end of 2019; companies whose boards have five or more directors will need to include two or three women by the end of 2021.

The of this legislation is right on target:

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.

Related Books & Audiobooks